Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 79-86 , April 2010

Spread-out antiproton beams deliver poor physical dose distributions for radiation therapy

  • Harald Paganetti

      Affiliations

    • Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
    • Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, Massachusetts General Hospital, Francis H Burr Proton Therapy Center, Boston, MA 02114, USA.
  • ,
  • Michael Goitein

      Affiliations

    • Harvard Medical School, Boston, MA, USA
  • ,
  • Katia Parodi

      Affiliations

    • Heidelberg Ion-Beam Therapy Centre, Heidelberg, Germany

Received 11 September 2008 ,Revised 11 March 2009 ,Accepted 14 March 2009.

References 

  1. Maggiore C. Antiprotons target cancer. Phys World. 2003;12:
  2. Agazaryan N, DeMarco JJ, Lee SP, et al. Investigation on the use of anti-protons in clinical radiotherapy. Radiother Oncol. 2002;64:S52;(Abstract)
  3. Holzscheiter MH, Agazaryan N, Bassler N, et al. Biological effectiveness of antiproton annihilation. Nuclear Instrum Methods Phys Res B. 2004;221:210–214
  4. Lewis RA, Smith GA, Howe SD. Antiproton portable traps and medical applications. Hyperfine Interact. 1997;107:155–164
  5. Withers HR, Lee SP, McBride W, et al. Potential for a radiotherapeutic gain from an anti-proton beam. Radiother Oncol. 2002;64:S93
  6. Bassler N, Alsner J, Beyer G, et al. Antiproton radiotherapy. Radiother Oncol. 2008;86:14–19
  7. Bassler N, Holzscheiter MH, Jakel O, Knudsen HV, Kovacevic S. The antiproton depth-dose curve in water. Phys Med Biol. 2008;53:793–805
  8. Hall EJ. Antiprotons for radiotherapy?. Radiother Oncol. 2006;81:231–232
  9. Gray L, Kalogeropoulos TE. Possible biomedical applications of antiproton beams: focused radiation transfer. Radiat Res. 1984;97:246–252
  10. Maggiore C, Agazaryan N, Bassler N, et al. Biological effectiveness of antiproton annihilation. Nuclear Instrum Methods Phys Res B. 2004;214:181–185
  11. Holzscheiter MH, Bassler N, Agazaryan N, et al. The biological effectiveness of antiproton irradiation. Radiother Oncol. 2006;81:233–242
  12. Agostinelli S, Allison J, Amako K, et al. GEANT4 – a simulation toolkit. Nuclear Instrum Methods Phys Res. 2003;A 506:250–303
  13. Paganetti H. Monte Carlo calculations for absolute dosimetry to determine output factors for proton therapy treatments. Phys Med Biol. 2006;51:2801–2812
  14. Paganetti H, Gottschalk B. Test of Geant3 and Geant4 nuclear models for 160MeV protons stopping in CH2. Med Phys. 2003;30:1926–1931
  15. Paganetti H, Jiang H, Lee S-Y, Kooy H. Accurate Monte Carlo for nozzle design, commissioning, and quality assurance in proton therapy. Med Phys. 2004;31:2107–2118
  16. Zacharatou-Jarlskog C, Paganetti H. Physics settings for using the Geant4 toolkit in proton therapy. IEEE Trans Nucl Sci. 2008;55:1018–1025
  17. Ferrari A, Sala PR, Fasso A, Ranft J. FLUKA: a multi-particle transport code. CERN Yellow Report CERN 2005-10; INFN/TC 05/11, SLAC-R-773. Geneva: CERN; 2005.
  18. Sullivan AH. A measurement of the local energy deposition by antiprotons coming to rest in tissue-like material. Phys Med Biol. 1985;30:1297–1303
  19. Clover MR, DeVries RM, DiGiacomo NJ, Yariv Y. Low energy antiproton–nucleus interactions. Phys Rev C. 1982;26:2138–2151
  20. Paganetti H, Niemierko A, Ancukiewicz M, et al. Relative biological effectiveness (RBE) values for proton beam therapy. Int J Radiat Oncol Biol Phys. 2002;53:407–421
  21. Raju MR, Amols HI, Bain E, Carpenter SG, Cox RA, Robertson JB. A heavy particle comparative study. Part III: OER and RBE. Br J Radiol. 1978;51:712–719
  22. Raju MR, Bain E, Carpenter SG, Cox RA, Robertson JB. A heavy particle comparative study. Part II: cell survival versus depth. Br J Radiol. 1978;51:704–711
  23. Wilkens JJ, Oelfke U. Direct comparison of biologically optimized spread-out Bragg peaks for protons and carbon ions. Int J Radiat Oncol Biol Phys. 2008;70:262–266
  24. Bertin A, Bruschi M, Capponi M, et al. pp annihilation cross section at very low energy. Phys Lett B. 1996;369:77–85
  25. Bianconi A, Bonomi G, Bussa MP, Lodi Rizzini E, Venturelli L, Zenoni A. A phenomenological analysis of antiproton interactions at low energies. Phys Lett B. 2000;483:353–359
  26. Barkas WH, Birge RW, Chupp WW, et al. Antiproton–nucleon annihilation process (antiproton collaboration experiment). Phys Rev. 1957;105:1037–1058
  27. Chamberlain O, Goldhaber G, Jauneau L, Kalogeropoulos T, Segre E, Silberberg R. Antiproton–nucleon annihilation process. II. Phys Rev. 1959;113:1615–1634
  28. Agnew LE, Elioff T, Fowler WB, et al. Antiproton interactions in hydrogen and carbon below 200MeV. Phys Rev. 1960;118:1371–1391
  29. Amsler C, Myhrer F. Low-energy anti-proton physics. Ann Rev Nucl Particle Sci. 1991;41:219–267
  30. Cossairt JD, Mokhov NV. Assessment of the prompt radiation hazards of trapped antiprotons. Health Phys. 2003;84:747–755
  31. Lu Y, Amado RD. Branching ratios in proton antiproton annihilation from Skyrmion dynamics. Phys Lett B. 1995;357:446–450
  32. Amsler C, Anisovich AV, Baker CA, et al. Annihilation at rest of antiprotons and protons into neutral particles. Nucl Phys A. 2003;720:357–367
  33. Hernandez JJ, Stone J, Porter FC, et al. Review of particle properties. Phys Lett B. 1990;239:1–516
  34. Abele A, Adomeit J, Amsler C, et al. Branching ratios for p_bar p annihilation at rest into two-body final states. Nucl Phys A. 2001;679:563–576
  35. Amsler C, Armstrong DS, Augustin I, et al. Observation of radiative p_bar p annihilation into a Φ meson. Phys Lett B. 1995;346:363–370
  36. Backenstoss G, Hasinoff M, Pavlopoulos P, et al. Proton–antiproton annihilations at rest into π0η, π0γ, π0π, π0π0, and π0η′. Nucl Phys. 1983;B228:424–438
  37. Benedettini A, Bertin A, Bruschi M, et al. pbar p partial cross sections at low energy. Nucl Phys B (Proc Suppl). 1997;56A:58–65

PII: S0167-8140(09)00141-8

doi: 10.1016/j.radonc.2009.03.020

Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 79-86 , April 2010